1. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. Issue 11 (November 2020) Authors: Jahnmatz, Maja; Richert, Laura; al-Tawil, Nabil; Storsaeter, Jann; Colin, Céline; Bauduin, Claire; Thalen, Marcel; Solovay, Ken; Rubin, Keith; Mielcarek, Nathalie; Thorstensson, Rigmor; Locht, Camille; Dager, Lena; Ekholm, Nina; Gustafsson, Margareta; Linde, Åsa; Lång, Cecilia; Nastase, Maria; Re... Journal: Lancet infectious diseases Issue: Volume 20:Issue 11(2020) Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗